Načítá se...
Many Distinct Ways Lead to Drug Resistance in BRAF- and NRAS-Mutated Melanomas
Advanced melanoma is a relentless tumor with a high metastatic potential. The combat of melanoma by using the targeted therapy is impeded because several major driver mutations fuel its growth (predominantly BRAF and NRAS). Both these mutated oncogenes strongly activate the MAPK (MEK/ERK) pathway. T...
Uloženo v:
| Vydáno v: | Life (Basel) |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8148104/ https://ncbi.nlm.nih.gov/pubmed/34063141 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/life11050424 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|